ARDELYX, INC. Payments to Acquire Short-term Investments
ARDELYX, INC. (ARDX) reported Payments to Acquire Short-term Investments of $81.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-08-06
- ARDELYX, INC. payments to acquire short-term investments for the quarter ending 2026-06-30 was $33.89M, a 48.55% increase year-over-year.
- ARDELYX, INC. payments to acquire short-term investments for the quarter ending 2026-03-31 was $47.88M, a 51.75% increase year-over-year.
- ARDELYX, INC. payments to acquire short-term investments for the quarter ending 2025-12-31 was $50.86M, a 48.38% decline year-over-year.
- ARDELYX, INC. payments to acquire short-term investments for the quarter ending 2025-09-30 was $113.70M, a 185.93% increase year-over-year.
- ARDELYX, INC. payments to acquire short-term investments for fiscal 2025 was $218.92M, a 12.18% increase from fiscal 2024.
- ARDELYX, INC. payments to acquire short-term investments for fiscal 2024 was $195.16M, a 9.32% decline from fiscal 2023.
- ARDELYX, INC. payments to acquire short-term investments for fiscal 2023 was $215.22M, a 327.64% increase from fiscal 2022.
- ARDELYX, INC. payments to acquire short-term investments for fiscal 2022 was $50.33M, a 30.81% decline from fiscal 2021.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $33.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $81.76M 10-Q · filed 2026-08-06 | $132.63M derived: sum of 3 quarters · filed 2026-08-06 | $246.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $47.88M 10-Q · filed 2026-04-30 | $98.74M derived: sum of 2 quarters · filed 2026-04-30 | $212.44M derived: sum of 3 quarters · filed 2026-04-30 | $235.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $50.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $164.56M derived: sum of 2 quarters · filed 2026-02-19 | $187.37M derived: sum of 3 quarters · filed 2026-08-06 | $218.92M 10-K · filed 2026-02-19 |
| 2025-09-30 | $113.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $136.51M derived: sum of 2 quarters · filed 2026-08-06 | $168.06M 10-Q · filed 2025-10-30 | $266.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $22.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $54.36M 10-Q · filed 2026-08-06 | $152.89M derived: sum of 3 quarters · filed 2026-08-06 | $192.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $31.55M 10-Q · filed 2026-04-30 | $130.08M derived: sum of 2 quarters · filed 2026-04-30 | $169.84M derived: sum of 3 quarters · filed 2026-04-30 | $192.69M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $98.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $138.29M derived: sum of 2 quarters · filed 2026-02-19 | $161.14M derived: sum of 3 quarters · filed 2026-02-19 | $195.16M 10-K · filed 2026-02-19 |
| 2024-09-30 | $39.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $62.61M derived: sum of 2 quarters · filed 2025-10-30 | $96.63M 10-Q · filed 2025-10-30 | $174.22M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $22.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $56.87M 10-Q · filed 2025-08-04 | $134.45M derived: sum of 3 quarters · filed 2026-02-19 | $183.97M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $34.02M 10-Q · filed 2025-05-01 | $111.61M derived: sum of 2 quarters · filed 2026-02-19 | $161.12M derived: sum of 3 quarters · filed 2026-02-19 | $228.49M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $77.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $127.10M derived: sum of 2 quarters · filed 2026-02-19 | $194.46M derived: sum of 3 quarters · filed 2026-02-19 | $215.22M 10-K · filed 2026-02-19 |
| 2023-09-30 | $49.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $116.88M derived: sum of 2 quarters · filed 2024-10-31 | $137.64M 10-Q · filed 2024-10-31 | $144.15M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $67.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $88.13M 10-Q · filed 2024-08-01 | $94.63M derived: sum of 3 quarters · filed 2025-02-20 | $112.69M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $20.76M 10-Q · filed 2024-05-02 | $27.27M derived: sum of 2 quarters · filed 2025-02-20 | $45.33M derived: sum of 3 quarters · filed 2025-02-20 | $45.33M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $24.57M derived: sum of 2 quarters · filed 2025-02-20 | $24.57M derived: sum of 3 quarters · filed 2025-02-20 | $50.33M 10-K · filed 2025-02-20 |
| 2022-09-30 | $18.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $18.06M derived: sum of 2 quarters · filed 2023-10-31 | $43.82M 10-Q · filed 2023-10-31 | $43.82M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $25.76M 10-Q · filed 2023-08-02 | $25.76M derived: sum of 3 quarters · filed 2024-02-22 | $50.18M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $25.76M 10-Q · filed 2023-05-03 | $25.76M derived: sum of 2 quarters · filed 2024-02-22 | $50.18M derived: sum of 3 quarters · filed 2024-02-22 | $66.39M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $24.42M derived: sum of 2 quarters · filed 2024-02-22 | $40.63M derived: sum of 3 quarters · filed 2024-02-22 | $72.73M 10-K · filed 2024-02-22 |
| 2021-09-30 | $24.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $40.63M derived: sum of 2 quarters · filed 2022-11-03 | $72.74M 10-Q · filed 2022-11-03 | $116.39M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $16.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $48.31M 10-Q · filed 2022-08-04 | $91.97M derived: sum of 3 quarters · filed 2023-03-02 | $136.21M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $32.11M 10-Q · filed 2022-05-05 | $75.76M derived: sum of 2 quarters · filed 2023-03-02 | $120.00M derived: sum of 3 quarters · filed 2023-03-02 | $128.10M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $43.65M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $87.89M derived: sum of 2 quarters · filed 2023-03-02 | $95.99M derived: sum of 3 quarters · filed 2023-03-02 | $150.85M 10-K · filed 2023-03-02 |
| 2020-09-30 | $44.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $52.34M derived: sum of 2 quarters · filed 2021-11-12 | $107.20M 10-Q · filed 2021-11-12 | $173.55M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $8.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $62.96M 10-Q · filed 2021-08-13 | $129.31M derived: sum of 3 quarters · filed 2022-02-28 | $134.77M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $54.86M 10-Q · filed 2021-05-06 | $121.20M derived: sum of 2 quarters · filed 2022-02-28 | $126.67M derived: sum of 3 quarters · filed 2022-02-28 | $132.66M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $66.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $71.81M derived: sum of 2 quarters · filed 2022-02-28 | $77.80M derived: sum of 3 quarters · filed 2022-02-28 | $102.67M 10-K · filed 2022-02-28 |
| 2019-09-30 | $5.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $11.45M derived: sum of 2 quarters · filed 2020-11-05 | $36.33M 10-Q · filed 2020-11-05 | $57.00M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-06-30 | $5.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $30.86M 10-Q · filed 2020-08-06 | $51.53M derived: sum of 3 quarters · filed 2021-03-08 | $80.87M derived: sum of 4 quarters · filed 2021-03-08 |
| 2019-03-31 | $24.87M 10-Q · filed 2020-05-07 | $45.55M derived: sum of 2 quarters · filed 2021-03-08 | $74.89M derived: sum of 3 quarters · filed 2021-03-08 | $154.89M derived: sum of 4 quarters · filed 2021-03-08 |
| 2018-12-31 | $20.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $50.01M derived: sum of 2 quarters · filed 2021-03-08 | $130.02M derived: sum of 3 quarters · filed 2021-03-08 | $169.03M 10-K · filed 2021-03-08 |
| 2018-09-30 | $29.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $109.34M derived: sum of 2 quarters · filed 2019-11-06 | $148.36M 10-Q · filed 2019-11-06 | $161.99M derived: sum of 4 quarters · filed 2020-03-06 |
| 2018-06-30 | $80.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $119.02M 10-Q · filed 2019-08-09 | $132.65M derived: sum of 3 quarters · filed 2020-03-06 | $158.29M derived: sum of 4 quarters · filed 2020-03-06 |
| 2018-03-31 | $39.02M 10-Q · filed 2019-05-07 | $52.64M derived: sum of 2 quarters · filed 2020-03-06 | $78.28M derived: sum of 3 quarters · filed 2020-03-06 | $104.76M derived: sum of 4 quarters · filed 2020-03-06 |
| 2017-12-31 | $13.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $39.27M derived: sum of 2 quarters · filed 2020-03-06 | $65.75M derived: sum of 3 quarters · filed 2020-03-06 | $84.01M 10-K · filed 2020-03-06 |
| 2017-09-30 | $25.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $52.12M derived: sum of 2 quarters · filed 2018-11-07 | $70.38M 10-Q · filed 2018-11-07 | $134.45M derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | $26.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $44.75M 10-Q · filed 2018-08-07 | $108.82M derived: sum of 3 quarters · filed 2019-03-06 | |
| 2017-03-31 | $18.27M 10-Q · filed 2018-05-08 | $82.34M derived: sum of 2 quarters · filed 2019-03-06 | ||
| 2016-12-31 | $64.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $133.81M 10-K · filed 2019-03-06 | ||
| 2016-09-30 | $69.74M 10-Q · filed 2017-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |